Successful treatment with dupilumab in a patient with severe, difficult to treat atopic dermatitis: Beware of symptomatic adrenal insufficiency due to abrupt discontinuation of potent topical corticosteroids

Lieneke F.M. Ariens; Jorien van der Schaft; Aline M.E. Stades; Anthonie A. van de Woestijne; Marjolein S. De Bruin-Weller

doi:10.2340/00015555-2936

Successful treatment with dupilumab in a patient with severe, difficult to treat atopic dermatitis: Beware of symptomatic adrenal insufficiency due to abrupt discontinuation of potent topical corticosteroids

Lieneke F.M. Ariens
, Jorien van der Schaft
, Aline M.E. Stades
, Anthonie A. van de Woestijne
, Marjolein S. De Bruin-Weller

Research output: Contribution to journal › Editorial › Academic › peer-review

9 Downloads (Pure)

Original language	English
Pages (from-to)	601-602
Number of pages	2
Journal	Acta Dermato-Venereologica
Volume	98
Issue number	6
DOIs	https://doi.org/10.2340/00015555-2936
Publication status	Published - 8 Jun 2018

Keywords

Administration, Cutaneous
Adrenal Cortex Hormones/administration & dosage
Adrenal Insufficiency/blood
Antibodies, Monoclonal/therapeutic use
Antibodies, Monoclonal, Humanized
Betamethasone/administration & dosage
Biomarkers/blood
Dermatitis, Atopic/diagnosis
Drug Substitution/adverse effects
Humans
Hydrocortisone/administration & dosage
Male
Middle Aged
Remission Induction
Severity of Illness Index
Treatment Outcome

Access to Document

10.2340/00015555-2936Licence: CC BY-NC

ariensFinal published version, 495 KBLicence: CC BY-NC

Cite this

Ariens, L. F. M., van der Schaft, J., Stades, A. M. E., van de Woestijne, A. A., & De Bruin-Weller, M. S. (2018). Successful treatment with dupilumab in a patient with severe, difficult to treat atopic dermatitis: Beware of symptomatic adrenal insufficiency due to abrupt discontinuation of potent topical corticosteroids. Acta Dermato-Venereologica, 98(6), 601-602. https://doi.org/10.2340/00015555-2936

@article{cfee47e6356a4cb9b1eb3435670b36f0,

title = "Successful treatment with dupilumab in a patient with severe, difficult to treat atopic dermatitis: Beware of symptomatic adrenal insufficiency due to abrupt discontinuation of potent topical corticosteroids",

keywords = "Administration, Cutaneous, Adrenal Cortex Hormones/administration \& dosage, Adrenal Insufficiency/blood, Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal, Humanized, Betamethasone/administration \& dosage, Biomarkers/blood, Dermatitis, Atopic/diagnosis, Drug Substitution/adverse effects, Humans, Hydrocortisone/administration \& dosage, Male, Middle Aged, Remission Induction, Severity of Illness Index, Treatment Outcome",

author = "Ariens, \{Lieneke F.M.\} and \{van der Schaft\}, Jorien and Stades, \{Aline M.E.\} and \{van de Woestijne\}, \{Anthonie A.\} and \{De Bruin-Weller\}, \{Marjolein S.\}",

note = "Funding Information: The patient described in this case report participated in 2 phase III dupilumab clinical trials sponsored by Regeneron.",

year = "2018",

month = jun,

day = "8",

doi = "10.2340/00015555-2936",

language = "English",

volume = "98",

pages = "601--602",

journal = "Acta Dermato-Venereologica",

issn = "0001-5555",

publisher = "Medical Journals Sweden AB",

number = "6",

}

Ariens, LFM, van der Schaft, J, Stades, AME, van de Woestijne, AA & De Bruin-Weller, MS 2018, 'Successful treatment with dupilumab in a patient with severe, difficult to treat atopic dermatitis: Beware of symptomatic adrenal insufficiency due to abrupt discontinuation of potent topical corticosteroids', Acta Dermato-Venereologica, vol. 98, no. 6, pp. 601-602. https://doi.org/10.2340/00015555-2936

Successful treatment with dupilumab in a patient with severe, difficult to treat atopic dermatitis: Beware of symptomatic adrenal insufficiency due to abrupt discontinuation of potent topical corticosteroids. / Ariens, Lieneke F.M.; van der Schaft, Jorien; Stades, Aline M.E. et al.
In: Acta Dermato-Venereologica, Vol. 98, No. 6, 08.06.2018, p. 601-602.

Research output: Contribution to journal › Editorial › Academic › peer-review

TY - JOUR

T1 - Successful treatment with dupilumab in a patient with severe, difficult to treat atopic dermatitis

T2 - Beware of symptomatic adrenal insufficiency due to abrupt discontinuation of potent topical corticosteroids

AU - Ariens, Lieneke F.M.

AU - van der Schaft, Jorien

AU - Stades, Aline M.E.

AU - van de Woestijne, Anthonie A.

AU - De Bruin-Weller, Marjolein S.

N1 - Funding Information: The patient described in this case report participated in 2 phase III dupilumab clinical trials sponsored by Regeneron.

PY - 2018/6/8

Y1 - 2018/6/8

KW - Administration, Cutaneous

KW - Adrenal Cortex Hormones/administration & dosage

KW - Adrenal Insufficiency/blood

KW - Antibodies, Monoclonal/therapeutic use

KW - Antibodies, Monoclonal, Humanized

KW - Betamethasone/administration & dosage

KW - Biomarkers/blood

KW - Dermatitis, Atopic/diagnosis

KW - Drug Substitution/adverse effects

KW - Humans

KW - Hydrocortisone/administration & dosage

KW - Male

KW - Middle Aged

KW - Remission Induction

KW - Severity of Illness Index

KW - Treatment Outcome

UR - https://www.scopus.com/pages/publications/85048507728

U2 - 10.2340/00015555-2936

DO - 10.2340/00015555-2936

M3 - Editorial

C2 - 29881868

AN - SCOPUS:85048507728

SN - 0001-5555

VL - 98

SP - 601

EP - 602

JO - Acta Dermato-Venereologica

JF - Acta Dermato-Venereologica

IS - 6

ER -

Ariens LFM, van der Schaft J, Stades AME, van de Woestijne AA, De Bruin-Weller MS. Successful treatment with dupilumab in a patient with severe, difficult to treat atopic dermatitis: Beware of symptomatic adrenal insufficiency due to abrupt discontinuation of potent topical corticosteroids. Acta Dermato-Venereologica. 2018 Jun 8;98(6):601-602. doi: 10.2340/00015555-2936

Successful treatment with dupilumab in a patient with severe, difficult to treat atopic dermatitis: Beware of symptomatic adrenal insufficiency due to abrupt discontinuation of potent topical corticosteroids

Keywords

Access to Document

Other files and links

Cite this